Host-Bacterial Interactions in Helicobacter pylori Infection

Gastroenterology

Volumn 134, Issue 1, 2008, Pages 306-323

  Amieva, Manuel R ^a   El Omar, Emad M ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; CAGA PROTEIN; CARBON DIOXIDE; CYTOKINE; GLYCOSAMINOGLYCAN; GROWTH FACTOR RECEPTOR; HLA ANTIGEN CLASS 1; PROTEIN TYROSINE KINASE; UREASE; VACUOLATING TOXIN;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; CELL ADHESION; CELL DAMAGE; CELL INTERACTION; CELL JUNCTION; CELL ONCOGENE; CELL PROLIFERATION; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIUM CELL; EXOCYTOSIS; GENE CLUSTER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HELICOBACTER PYLORI; HEREDITY; HOST PATHOGEN INTERACTION; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; METAPLASIA; MUCUS EPITHELIAL CELL; NONHUMAN; PATHOGENESIS; PATHOGENICITY ISLAND; PATHOPHYSIOLOGY; PERISTALSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RISK FACTOR; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH MUCOSA; STOMACH PH; STOMACH SECRETION; TREATMENT OUTCOME; VIRULENCE; VIRUS REPLICATION;

EID: 37349009928     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.11.009     Document Type: Article

References (173)

1. Hunt R.H. The role of Helicobacter pylori in pathogenesis: the spectrum of clinical outcomes. Scand J Gastroenterol Suppl 220 (1996) 3-9
2. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 61. Schistosomes, liver flukes and Helicobacter pylori (1994), IARC, Lyon, France 177-240
3. Blaser M.J. The versatility of Helicobacter pylori in the adaptation to the human stomach. J Physiol Pharmacol 48 (1997) 307-314
4. Terio K.A., Munson L., Marker L., et al. Comparison of Helicobacter spp. in Cheetahs (Acinonyx jubatus) with and without gastritis. J Clin Microbiol 43 (2005) 229-234
5. Oxley A.P., Argo J.A., and McKay D.B. Helicobacter spp. from captive bottlenose dolphins (Tursiops spp.) and polar bears (Ursus maritimus). Vet J 170 (2005) 377-380
6. Harper C.M., Dangler C.A., Xu S., et al. Isolation and characterization of a Helicobacter sp. from the gastric mucosa of dolphins, Lagenorhynchus acutus, and Delphinus delphis. Appl Environ Microbiol 66 (2000) 4751-4757
7. Falush D., Wirth T., Linz B., et al. Traces of human migrations in Helicobacter pylori populations. Science 299 (2003) 1582-1585
8. Linz B., Balloux F., Moodley Y., et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature 445 (2007) 915-918
9. Bardhan P.K. Epidemiological features of Helicobacter pylori infection in developing countries. Clin Infect Dis 25 (1997) 973-978
10. Weyermann M., Adler G., Brenner H., et al. The mother as source of Helicobacter pylori infection. Epidemiology 17 (2006) 332-334
11. Kivi M., Johansson A.L., Reilly M., et al. Helicobacter pylori status in family members as risk factors for infection in children. Epidemiol Infect 133 (2005) 645-652
12. McCallion W.A., Murray L.J., Bailie A.G., et al. Helicobacter pylori infection in children: relation with current household living conditions. Gut 39 (1996) 18-21
13. Brown L.M. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22 (2000) 283-297
14. Graham D.Y., Opekun A.R., Osato M.S., et al. Challenge model for Helicobacter pylori infection in human volunteers. Gut 53 (2004) 1235-1243
15. Tytgat G.N. Endoscopic transmission of Helicobacter pylori. Aliment Pharmacol Ther 9 Suppl 2 (1995) 105-110
16. Hamblin M.R., Viveiros J., Yang C., et al. Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light. Antimicrob Agents Chemother 49 (2005) 2822-2827
17. Perry S., de la Luz S.M., Yang S., et al. Gastroenteritis and transmission of Helicobacter pylori infection in households. Emerg Infect Dis 12 (2006) 1701-1708
18. Leung W.K., Siu K.L., Kwok C.K., et al. Isolation of Helicobacter pylori from vomitus in children and its implication in gastro-oral transmission. Am J Gastroenterol 94 (1999) 2881-2884
19. Parsonnet J., Shmuely H., and Haggerty T. Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA 282 (1999) 2240-2245
20. Solnick J.V., Fong J., Hansen L.M., et al. Acquisition of Helicobacter pylori infection in rhesus macaques is most consistent with oral-oral transmission. J Clin Microbiol 44 (2006) 3799-3803
21. Chaput C., Ecobichon C., Cayet N., et al. Role of AmiA in the morphological transition of Helicobacter pylori and in immune escape. PLoS Pathog 2 (2006) e97
22. Nagai S., Mimuro H., Yamada T., et al. Role of Peyer's patches in the induction of Helicobacter pylori-induced gastritis. Proc Natl Acad Sci U S A 104 (2007) 8971-8976
23. Merrell D.S., Goodrich M.L., Otto G., et al. pH-regulated gene expression of the gastric pathogen Helicobacter pylori. Infect Immun 71 (2003) 3529-3539
24. Pflock M., Kennard S., Finsterer N., et al. Acid-responsive gene regulation in the human pathogen Helicobacter pylori. J Biotechnol 126 (2006) 52-60
25. Schreiber S., Nguyen T.H., Konradt M., et al. Recovery from gastric mucus depletion in the intact guinea pig mucosa. Scand J Gastroenterol 38 (2003) 1136-1143
26. McGee D.J., Langford M.L., Watson E.L., et al. Colonization and inflammation deficiencies in Mongolian gerbils infected by Helicobacter pylori chemotaxis mutants. Infect Immun 73 (2005) 1820-1827
27. Ottemann K.M., and Lowenthal A.C. Helicobacter pylori uses motility for initial colonization and to attain robust infection. Infect Immun 70 (2002) 1984-1990
28. Schreiber S., Konradt M., Groll C., et al. The spatial orientation of Helicobacter pylori in the gastric mucus. Proc Natl Acad Sci U S A 101 (2004) 5024-5029
29. Schreiber S., Bucker R., Groll C., et al. Rapid loss of motility of Helicobacter pylori in the gastric lumen in vivo. Infect Immun 73 (2005) 1584-1589
30. Croxen M.A., Sisson G., Melano R., et al. The Helicobacter pylori chemotaxis receptor TlpB (HP0103) is required for pH taxis and for colonization of the gastric mucosa. J Bacteriol 188 (2006) 2656-2665
31. Nowak J.A., Forouzandeh B., and Nowak J.A. Estimates of Helicobacter pylori densities in the gastric mucus layer by PCR, histologic examination, and CLOtest. Am J Clin Pathol 108 (1997) 284-288
32. Hessey S.J., Spencer J., Wyatt J.I., et al. Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut 31 (1990) 134-138
33. Steer H.W. Surface morphology of the gastroduodenal mucosa in duodenal ulceration. Gut 25 (1984) 1203-1210
34. Hazell S.L., Lee A., Brady L., et al. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis 153 (1986) 658-663
35. Noach L.A., Rolf T.M., and Tytgat G.N. Electron microscopic study of association between Helicobacter pylori and gastric and duodenal mucosa. J Clin Pathol 47 (1994) 699-704
36. Camorlinga-Ponce M., Romo C., Gonzalez-Valencia G., et al. Topographical localisation of cagA positive and cagA negative Helicobacter pylori strains in the gastric mucosa: an in situ hybridisation study. J Clin Pathol 57 (2004) 822-828
37. Necchi V., Candusso M.E., Tava F., et al. Intracellular, intercellular, and stromal invasion of gastric mucosa, preneoplastic lesions, and cancer by Helicobacter pylori. Gastroenterology 132 (2007) 1009-1023
38. Ilver D., Arnqvist A., Ogren J., et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279 (1998) 373-377
39. Mahdavi J., Sonden B., Hurtig M., et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 297 (2002) 573-578
40. Peck B., Ortkamp M., Diehl K.D., et al. Conservation, localization and expression of HopZ, a protein involved in adhesion of Helicobacter pylori. Nucleic Acids Res 27 (1999) 3325-3333
41. Dossumbekova A., Prinz C., Mages J., et al. Helicobacter pylori HopH (OipA) and bacterial pathogenicity: genetic and functional genomic analysis of hopH gene polymorphisms. J Infect Dis 194 (2006) 1346-1355
42. Dossumbekova A., Prinz C., Gerhard M., et al. Helicobacter pylori outer membrane proteins and gastric inflammation. Gut 55 (2006) 1360-1361
43. de Jonge R., Durrani Z., Rijpkema S.G., et al. Role of the Helicobacter pylori outer-membrane proteins AlpA and AlpB in colonization of the guinea pig stomach. J Med Microbiol 53 (2004) 375-379
44. O'Brien D.P., Israel D.A., Krishna U., et al. The role of decay-accelerating factor as a receptor for Helicobacter pylori and a mediator of gastric inflammation. J Biol Chem 281 (2006) 13317-13323
45. Coyne C.B., and Bergelson J.M. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124 (2006) 119-131
46. Aspholm-Hurtig M., Dailide G., Lahmann M., et al. Functional adaptation of BabA, the H pylori ABO blood group antigen binding adhesin. Science 305 (2004) 519-522
47. Solnick J.V., Hansen L.M., Salama N.R., et al. Modification of Helicobacter pylori outer membrane protein expression during experimental infection of rhesus macaques. Proc Natl Acad Sci U S A 101 (2004) 2106-2111
48. de Jonge R., Pot R.G., Loffeld R.J., et al. The functional status of the Helicobacter pylori sabB adhesin gene as a putative marker for disease outcome. Helicobacter 9 (2004) 158-164
49. Aspholm M., Olfat F.O., Norden J., et al. SabA is the H pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog 2 (2006) e110
50. Prinz C., Schoniger M., Rad R., et al. Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res 61 (2001) 1903-1909
51. Petersson C., Forsberg M., Aspholm M., et al. Helicobacter pylori SabA adhesin evokes a strong inflammatory response in human neutrophils which is down-regulated by the neutrophil-activating protein. Med Microbiol Immunol 195 (2006) 195-206
52. Guruge J.L., Falk P.G., Lorenz R.G., et al. Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci U S A 95 (1998) 3925-3930
53. Mulvey M.A., Lopez-Boado Y.S., et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282 (1998) 1494-1497
54. Martinez J.J., Mulvey M.A., Schilling J.D., et al. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J 19 (2000) 2803-2812
55. Amieva M.R., Salama N.R., Tompkins L.S., et al. Helicobacter pylori enter and survive within multivesicular vacuoles of epithelial cells. Cell Microbiol 4 (2002) 677-690
56. Dubois A., and Boren T. Helicobacter pylori is invasive and it may be a facultative intracellular organism. Cell Microbiol 9 (2007) 1108-1116
57. Wunder C., Churin Y., Winau F., et al. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med 12 (2006) 1030-1038
58. Wilson K.T., and Crabtree J.E. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology 133 (2007) 288-308
59. Leunk R.D., Johnson P.T., David B.C., et al. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 26 (1988) 93-99
60. Iwamoto H., Czajkowsky D.M., Cover T.L., et al. VacA from Helicobacter pylori: a hexameric chloride channel. FEBS Lett 450 (1999) 101-104
61. Atherton J.C., Cao P., and Peek Jr. R.M. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 270 (1995) 17771-17777
62. Nguyen V.Q., Caprioli R.M., and Cover T.L. Carboxy-terminal proteolytic processing of Helicobacter pylori vacuolating toxin. Infect Immun 69 (2001) 543-546
63. Cover T.L., Tummuru M.K., Cao P., et al. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 269 (1994) 10566-10573
64. Ilver D., Barone S., Mercati D., et al. Helicobacter pylori toxin VacA is transferred to host cells via a novel contact-dependent mechanism. Cell Microbiol 6 (2004) 167-174
65. Reyrat J.M., Rappuoli R., and Telford J.L. A structural overview of the Helicobacter cytotoxin. Int J Med Microbiol 290 (2000) 375-379
66. Cover T.L., Hanson P.I., and Heuser J.E. Acid-induced dissociation of VacA, the Helicobacter pylori vacuolating cytotoxin, reveals its pattern of assembly. J Cell Biol 138 (1997) 759-769
67. Czajkowsky D.M., Iwamoto H., Cover T.L., et al. The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH. Proc Natl Acad Sci U S A 96 (1999) 2001-2006
68. Molinari M., Salio M., Galli C., et al. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J Exp Med 187 (1998) 135-140
69. Willhite D.C., and Blanke S.R. Helicobacter pylori vacuolating cytotoxin enters cells, localizes to the mitochondria, and induces mitochondrial membrane permeability changes correlated to toxin channel activity. Cell Microbiol 6 (2004) 143-154
70. Yamasaki E., Wada A., Kumatori A., et al. Helicobacter pylori vacuolating cytotoxin induces activation of the proapoptotic proteins Bax and Bak, leading to cytochrome c release and cell death, independent of vacuolation. J Biol Chem 281 (2006) 11250-11259
71. Fujikawa A., Shirasaka D., Yamamoto S., et al. Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat Genet 33 (2003) 375-381
72. Papini E., Satin B., Norais N., et al. Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin. J Clin Invest 102 (1998) 813-820
73. Gebert B., Fischer W., Weiss E., et al. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301 (2003) 1099-1102
74. Ogura K., Maeda S., Nakao M., et al. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil. J Exp Med 192 (2000) 1601-1610
75. Salama N.R., Otto G., Tompkins L., et al. Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infect Immun 69 (2001) 730-736
76. Nomura A.M., Perez-Perez G.I., Lee J., et al. Relation between Helicobacter pylori cagA status and risk of peptic ulcer disease. Am J Epidemiol 155 (2002) 1054-1059
77. Blaser M.J., Perez-Perez G.I., Kleanthous H., et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55 (1995) 2111-2115
78. Wu A.H., Crabtree J.E., Bernstein L., et al. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer 103 (2003) 815-821
79. Huang J.Q., Zheng G.F., Sumanac K., et al. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 125 (2003) 1636-1644
80. Brenner H., Arndt V., Stegmaier C., et al. Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer?. Am J Epidemiol 159 (2004) 252-258
81. Peek Jr. R.M., Miller G.G., Tham K.T., et al. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest 73 (1995) 760-770
82. Peek Jr. R.M., Moss S.F., Tham K.T., et al. Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst 89 (1997) 863-868
83. Figura N., Vindigni C., Covacci A., et al. cagA positive and negative Helicobacter pylori strains are simultaneously present in the stomach of most patients with non-ulcer dyspepsia: relevance to histological damage. Gut 42 (1998) 772-778
84. Christie P.J., Atmakuri K., Krishnamoorthy V., et al. Biogenesis, architecture, and function of bacterial type IV secretion systems. Annu Rev Microbiol 59 (2005) 451-485
85. Censini S., Lange C., Xiang Z., et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A 93 (1996) 14648-14653
86. Segal E.D., Lange C., Covacci A., et al. Induction of host signal transduction pathways by Helicobacter pylori. Proc Natl Acad Sci U S A 94 (1997) 7595-7599
87. Segal E.D., Falkow S., and Tompkins L.S. Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phosphorylation of host cell proteins. Proc Natl Acad Sci U S A 93 (1996) 1259-1264
88. Segal E.D., Cha J., Lo J., et al. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci U S A 96 (1999) 14559-14564
89. Asahi M., Azuma T., Ito S., et al. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med 191 (2000) 593-602
90. Odenbreit S., Puls J., Sedlmaier B., et al. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287 (2000) 1497-1500
91. Stein M., Rappuoli R., and Covacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci U S A 97 (2000) 1263-1268
92. Backert S., Ziska E., Brinkmann V., et al. Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol 2 (2000) 155-164
93. Viala J., Chaput C., Boneca I.G., et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 5 (2004) 1166-1174
94. Stein M., Bagnoli F., Halenbeck R., et al. c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol 43 (2002) 971-980
95. Higashi H., Tsutsumi R., Fujita A., et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A 99 (2002) 14428-14433
96. Argent R.H., Kidd M., Owen R.J., et al. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 127 (2004) 514-523
97. Tammer I., Brandt S., Hartig R., et al. Activation of Abl by Helicobacter pylori: a novel kinase for CagA and crucial mediator of host cell scattering. Gastroenterology 132 (2007) 1309-1319
98. Schaeper U., Gehring N.H., Fuchs K.P., et al. Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses. J Cell Biol 149 (2000) 1419-1432
99. Hatakeyama M. Helicobacter pylori CagA-a potential bacterial oncoprotein that functionally mimics the mammalian Gab family of adaptor proteins. Microbes Infect 5 (2003) 143-150
100. Higashi H., Tsutsumi R., Muto S., et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295 (2002) 683-686
101. Churin Y., Al Ghoul L., Kepp O., et al. Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J Cell Biol 161 (2003) 249-255
102. Mimuro H., Suzuki T., Tanaka J., et al. Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol Cell 10 (2002) 745-755
103. Suzuki M., Mimuro H., Suzuki T., et al. Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion. J Exp Med 202 (2005) 1235-1247
104. Keates S., Keates A.C., Warny M., et al. Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cag- Helicobacter pylori. J Immunol 163 (1999) 5552-5559
105. Backert S., Moese S., Selbach M., et al. Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol Microbiol 42 (2001) 631-644
106. Chang Y.J., Wu M.S., Lin J.T., et al. Mechanisms for Helicobacter pylori CagA-induced cyclin D1 expression that affect cell cycle. Cell Microbiol 8 (2006) 1740-1752
107. Yokoyama K., Higashi H., Ishikawa S., et al. Functional antagonism between Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT signaling pathway in gastric epithelial cells. Proc Natl Acad Sci U S A 102 (2005) 9661-9666
108. Oliveira M.J., Costa A.C., Costa A.M., et al. Helicobacter pylori induces gastric epithelial cell invasion in a c-Met and type IV secretion system-dependent manner. J Biol Chem 281 (2006) 34888-34896
109. Bagnoli F., Buti L., Tompkins L., et al. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc Natl Acad Sci U S A 102 (2005) 16339-16344
110. Amieva M.R., Vogelmann R., Covacci A., et al. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300 (2003) 1430-1434
111. Murata-Kamiya N., Kurashima Y., Teishikata Y., et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the β-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 26 (2007) 4617-4626
112. Franco A.T., Israel D.A., Washington M.K., et al. Activation of β-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A 102 (2005) 10646-10651
113. Guillemin K., Salama N.R., Tompkins L.S., et al. Cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infection. Proc Natl Acad Sci U S A 99 (2002) 15136-15141
114. Yamazaki S., Yamakawa A., Ito Y., et al. The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. J Infect Dis 187 (2003) 334-337
115. Ohkusa T., Okayasu I., Miwa H., et al. Helicobacter pylori infection induces duodenitis and superficial duodenal ulcer in Mongolian gerbils. Gut 52 (2003) 797-803
116. Rieder G., Merchant J.L., and Haas R. Helicobacter pylori cag-type IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils. Gastroenterology 128 (2005) 1229-1242
117. Shibata W., Hirata Y., Maeda S., et al. CagA protein secreted by the intact type IV secretion system leads to gastric epithelial inflammation in the Mongolian gerbil model. J Pathol 210 (2006) 306-314
118. Brandt S., Kwok T., Hartig R., et al. NF-κB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci U S A 102 (2005) 9300-9305
119. Kim S.Y., Lee Y.C., Kim H.K., et al. Helicobacter pylori CagA transfection of gastric epithelial cells induces interleukin-8. Cell Microbiol 8 (2006) 97-106
120. Matsumoto Y., Marusawa H., Kinoshita K., et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med 13 (2007) 470-476
121. Mobley H.L., Hu L.T., and Foxal P.A. Helicobacter pylori urease: properties and role in pathogenesis. Scand J Gastroenterol Suppl 187 (1991) 39-46
122. Satin B., del Giudice G., Della B., et al. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med 191 (2000) 1467-1476
123. Gewirtz A.T., Yu Y., Krishna U.S., et al. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J Infect Dis 189 (2004) 1914-1920
124. Muotiala A., Helander I.M., Pyhala L., et al. Low biological activity of Helicobacter pylori lipopolysaccharide. Infect Immun 60 (1992) 1714-1716
125. Moran A.P., Knirel Y.A., Senchenkova S.N., et al. Phenotypic variation in molecular mimicry between Helicobacter pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. Acid-induced phase variation in Lewis(x) and Lewis(y) expression by H pylori lipopolysaccharides. J Biol Chem 277 (2002) 5785-5795
126. Appelmelk B.J., Monteiro M.A., Martin S.L., et al. Why Helicobacter pylori has Lewis antigens. Trends Microbiol 8 (2000) 565-570
127. Bamford K.B., Fan X., Crowe S.E., et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 114 (1998) 482-492
128. El-Omar E.M., Penman I.D., Ardill J.E., et al. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 109 (1995) 681-691
129. El-Omar E.M., Oien K., El Nujumi A., et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 113 (1997) 15-24
130. Naylor G.M., Gotoda T., Dixon M., et al. Why does Japan have a high incidence of gastric cancer?. Comparison of gastritis between UK and Japanese patients. Gut 55 (2006) 1545-1552
131. Kuipers E.J., Lundell L., Klinkenberg-Knol E.C., et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 334 (1996) 1018-1022
132. Kuipers E.J., Lee A., Klinkenberg-Knol E.C., et al. Review article: the development of atrophic gastritis-Helicobacter pylori and the effects of acid suppressive therapy. Aliment Pharmacol Ther 9 (1995) 331-340
133. El-Omar E.M. The importance of interleukin 1β in Helicobacter pylori associated disease. Gut 48 (2001) 743-747
134. El-Omar E.M., Carrington M., Chow W.H., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (2000) 398-402
135. El-Omar E.M., Rabkin C.S., Gammon M.D., et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124 (2003) 1193-1201
136. Ando T., El-Omar E.M., Goto Y., et al. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 55 (2006) 158-164
137. Queiroz D.M., Guerra J.B., Rocha G.A., et al. IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis. Gastroenterology 127 (2004) 73-79
138. Machado J.C., Pharoah P., Sousa S., et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121 (2001) 823-829
139. Figueiredo C., Machado J.C., Pharoah P., et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 94 (2002) 1680-1687
140. Machado J.C., Figueiredo C., Canedo P., et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 125 (2003) 364-371
141. Rad R., Prinz C., Neu B., et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 188 (2003) 272-281
142. Palli D., Saieva C., Luzzi I., et al. Interleukin-1 gene polymorphisms and gastric cancer risk in a high-risk Italian population. Am J Gastroenterol 100 (2005) 1941-1948
143. Furuta T., El-Omar E.M., Xiao F., et al. Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 123 (2002) 92-105
144. Zeng Z.R., Hu P.J., Hu S., et al. Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut 52 (2003) 1684-1689
145. Garza-Gonzalez E., Bosques-Padilla F.J., El-Omar E., et al. Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int J Cancer 114 (2005) 237-241
146. Wang P., Xia H.H., Zhang J.Y., et al. Association of interleukin-1 gene polymorphisms with gastric cancer: a meta-analysis. Int J Cancer 120 (2007) 552-562
147. Camargo M.C., Mera R., Correa P., et al. Interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15 (2006) 1674-1687
148. Kamangar F., Cheng C., Abnet C.C., et al. Interleukin-1B polymorphisms and gastric cancer risk-a meta-analysis. Cancer Epidemiol Biomarkers Prev 15 (2006) 1920-1928
149. Tu S., Cui G., Takaishi S., et al. Overexpression of human interleukin-1 β in transgenic mice results in spontaneous gastric inflammation and carcinogenesis. Gastroenterology 128 Suppl 2 (2005) A62
150. Tu S., Cui G., Takaishi S., et al. Overexpression of IL-1β induced gastric inflammation and carcinoma through dysfunction of immunity and change of gastric microenvironment in transgenic mice. Gastroenterology 132 Suppl 2 (2007) A-5
151. Beales I.L., and Calam J. Interleukin 1 β and tumour necrosis factor α inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 42 (1998) 227-234
152. Smith M.G., Hold G.L., Rabkin C.S., et al. The IL-8-251 promoter polymorphism is associated with high IL-8 production, severe inflammation and increased risk of pre-malignant changes in H pylori positive subjects. Gastroenterology 124 Suppl 2 (2004) A23
153. Taguchi A., Ohmiya N., Shirai K., et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 14 (2005) 2487-2493
154. Lu W., Pan K., Zhang L., et al. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor α and risk of gastric cancer in a Chinese population. Carcinogenesis 26 (2005) 631-636
155. Lee W.P., Tai D.I., Lan K.H., et al. The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res 11 (2005) 6431-6441
156. Ohyauchi M., Imatani A., Yonechi M., et al. The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 54 (2005) 330-335
157. Smith M.G., Hold G.L., Rabkin C.S., et al. The interleukin-8-251 promoter polymorphism and risk of gastric cancer in Caucasian and Japanese populations. Gastroenterology 128 Suppl 2 (2006) A-19
158. Su B., Ceponis P.J., Lebel S., et al. Helicobacter pylori activates Toll-like receptor 4 expression in gastrointestinal epithelial cells. Infect Immun 71 (2003) 3496-3502
159. Pasare C., and Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol 560 (2005) 11-18
160. Takeda K., and Akira S. Toll-like receptors in innate immunity. Int Immunol 17 (2005) 1-14
161. Arbour N.C., Lorenz E., Schutte B.C., et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25 (2000) 187-191
162. Franchimont D., Vermeire S., El Housni H., et al. Deficient host-bacteria interactions in inflammatory bowel disease?. The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53 (2004) 987-992
163. Lorenz E., Mira J.P., Frees K.L., et al. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 162 (2002) 1028-1032
164. Kiechl S., Lorenz E., Reindl M., et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347 (2002) 185-192
165. Higgins S.C., Lavelle E.C., McCann C., et al. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J Immunol 171 (2003) 3119-3127
166. Hold G.L., Rabkin C.S., Chow W.H., et al. A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 132 (2007) 905-912
167. Sanduleanu S., Jonkers D., De Bruine A., et al. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis. Aliment Pharmacol Ther 15 (2001) 1163-1175
168. Zavros Y., Rieder G., Ferguson A., et al. Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice. Gastroenterology 122 (2002) 119-133
169. Bik E.M., Eckburg P.B., Gill S.R., et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A 103 (2006) 732-737
170. Baccarelli A., Hou L., Chen J., et al. Mannose-binding lectin-2 genetic variation and stomach cancer risk. Int J Cancer 119 (2006) 1970-1975
171. Lee J.E., Lowy A.M., Thompson W.A., et al. Association of gastric adenocarcinoma with the HLA class II gene DQB10301. Gastroenterology 111 (1996) 426-432
172. Azuma T., Ito S., Sato F., et al. The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer 82 (1998) 1013-1018
173. Magnusson P.K.E., Enroth H., Eriksson I., et al. Gastric cancer and human leukocyte antigen: distinct DQ and DR alleles are associated with development of gastric cancer and infection by Helicobacter pylori. Cancer Res 61 (2001) 2684-2689